Address
Email address
Phone number
https://hambaravi.netAvaleht - HambaraviHambaravi Terved hambad ja igemed mitte ainult ei paranda meie enesetunnet ja enesehinnangut, vaid aitavad vältida ka mitmeid terviseprobleeme, sealhulgas südamehaigusi ja diabeeti. Hambaravi on oluline osa meie üldisest tervisest ja heaolust. Broneeri aeg: Kontakt Suuhügieen mõjutab kogu organismi tervist ja seetõttu on regulaarne hambaarsti külastamine ja õigete hooldusmeetodite järgimine äärmiselt oluline. Terved hambad ja...
Name
OÜ Medical Consulting
Registry code
11140939
VAT number
EE100972410
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
12.05.2005 (19)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
82991 - Other business support service activities n.e.c.
-
-
-
-
-
-
Not submitted
10 442 €
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Mehis Mõttus 13.04.1959 (65) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
| Meeme Mõttus 30.09.1969 (54) | - | - | - | Founder |
| 2019 14.06.2021 | |
|---|---|
| Total Revenue | 17 291 € |
| Net profit (loss) for the period | 6 255 € |
| Profit Margin | 36% |
| Current Assets | 2 833 € |
| Fixed Assets | - |
| Total Assets | 2 833 € |
| Current Liabilities | 102 753 € |
| Non Current Liabilities | - |
| Total Liabilities | - |
| Share Capital | - |
| Equity | -99 920 € |
| Employees | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | - | - | - |
| 2023 Q4 | - | - | - | - |
| 2023 Q3 | - | - | - | - |
| 2023 Q2 | - | - | - | - |
| 2023 Q1 | - | - | - | - |
| 2022 Q4 | - | - | - | - |
| 2022 Q3 | - | - | - | - |
| 2022 Q2 | - | - | - | - |
| 2022 Q1 | 20 000 € | - | - | - |
| 2021 Q4 | 6 900 € | - | - | - |
| 2021 Q3 | - | - | - | - |
| 2021 Q2 | - | - | - | - |
| 2021 Q1 | - | - | - | - |
| 2020 Q4 | 26 290 € | 196.5 € | - | - |
| 2020 Q3 | - | - | - | - |
| 2020 Q2 | - | - | - | - |
| 2020 Q1 | 3 957.17 € | 86.2 € | - | - |
